🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to assess the overall response rate, evaluat...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2023-01-09
Trial ID
NCT05661955
Treatments Being Tested
Single centre, open-label, single dose, parallel group study to investigate...
Status
Completed
Location
Hammersmith Medicines Research
Start Date
2020-07-07
Trial ID
NCT04449939
Treatments Being Tested
This is an investigator-initiated clinical trial evaluating the safety, tol...
Status
Active Not Recruiting
Location
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Start Date
2024-12-30
Trial ID
NCT07461181
Treatments Being Tested
This phase Ib/II trial studies the side effects and best dose of anti-OX40 ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2017-12-27
Trial ID
NCT03390296
the main purpose: * Evaluate the safety and resistance of BAT6026 injectio...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2021-12-23
Trial ID
NCT05105971
Treatments Being Tested
This phase II trial studies how well the combination of avelumab with lipos...
Status
Active Not Recruiting
Location
O'Neal Comprehensive Cancer Center
Start Date
2019-07-08
Trial ID
NCT03971409
The purpose of this research study is to investigate if KY1005 results in i...
Status
Completed
Location
Kymab investigational site 106
Start Date
2018-12-13
Trial ID
NCT03754309
This is a Phase 1b/2 dose-optimization study to evaluate safety, pharmacoki...
Status
Terminated
Location
UCSD Medical Center - Encinitas
Start Date
2015-11-09
Trial ID
NCT02554812
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of ad...
Status
Completed
Location
Multiple Locations
Start Date
2016-06
Trial ID
NCT02647866
This study will test the ability of an immune modulator, anti-OX40 (MEDI646...
Status
Terminated
Location
Portland Providence Medical Center
Start Date
2016-03-14
Trial ID
NCT02559024
Treatments Being Tested